Park Square has placed Michael Aldridge as Chief Executive Officer at Focal Medical.
| less than a minute read
Michael Aldridge, Seasoned Biotech Executive, Appointed CEO of Focal Medical
Get in touch
Get in touch
Focal Medical, Inc. (formerly Advanced Chemotherapy Technologies, Inc.), a privately held, biopharmaceutical company developing novel therapeutic products based on its innovative local drug delivery technology platform, today announced the appointment of Michael Aldridge as the Company’s new Chief Executive Officer.
Get in touch
Get in touch
Latest Insights
